Ralliant Corporation (RAL) to Issue Quarterly Dividend of $0.05 on September 23rd

Ralliant Corporation (NYSE:RAL) announced a quarterly dividend on Tuesday, August 4th. Investors of record on Tuesday, September 8th will be given a dividend of 0.05 per share on Wednesday, September 23rd. This represents a c) dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th.

Ralliant Stock Performance

Shares of RAL stock opened at $66.38 on Thursday. The firm has a market cap of $7.34 billion, a price-to-earnings ratio of -6.12, a P/E/G ratio of 2.49 and a beta of 1.60. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. Ralliant has a 52 week low of $37.27 and a 52 week high of $75.41. The firm’s 50-day simple moving average is $67.45 and its two-hundred day simple moving average is $54.63.

Ralliant (NYSE:RAL) last released its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts forecast that Ralliant will post 2.87 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on RAL shares. Evercore began coverage on Ralliant in a research note on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price target for the company. Barclays lifted their price target on Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research report on Wednesday, May 13th. Truist Financial reissued a “buy” rating and issued a $82.00 price target (up from $68.00) on shares of Ralliant in a report on Friday, July 31st. Oppenheimer upped their target price on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Finally, Wall Street Zen raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.70.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.